Active Filters
- 2022Clear filter
Mar 31, 2022
The spring 2022 newsletter for Lung-MAP participating sites is now available.
Mar 25, 2022
Mar 4, 2022
Feb 18, 2022
Feb 15, 2022
Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO
Feb 14, 2022
Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy